Health
J&J starts human study of COVID-19 vaccine after promising monkey data – Yahoo Finance
When exposed to the virus, six out of six animals who got the vaccine candidate were completely protected from lung disease and five out of six were protected from infection as measured by the presence of virus in nasal swabs, according to the study published…
By Julie Steenhuysen
(Reuters) – Johnson & Johnson <JNJ.N> on Thursday kicked off U.S. human safety trials for its COVID-19 vaccine after releasing details of a study in monkeys that showed its best-performing vaccine candidate offered strong protection in a single dose.
When exposed to the virus, six out of six animals who got the vaccine candidate were completely protected from lung disease and five out of six were protected from infection as measured by the presence of virus in na…
-
General18 hours agoChina and Philippines trade blame over latest South China Sea clash
-
Noosa News22 hours agoBrisbane rising on global rankings, but still behind southern capitals
-
General18 hours agoSmall plane crashes into San Diego neighbourhood, setting homes and vehicles on fire
-
Noosa News8 hours agoTully Sugar Mill celebrates 100 years of cane harvesting amid floods and cyclones